We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.9B
AUM Growth
-$1.94B
Cap. Flow
-$1.04B
Cap. Flow %
-4.99%
Top 10 Hldgs %
40.27%
Holding
168
New
18
Increased
43
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$381M
2
MSFT icon
Microsoft
MSFT
+$266M
3
CRM icon
Salesforce
CRM
+$235M
4
K
Kellanova
K
+$186M
5
ARMK icon
Aramark
ARMK
+$178M

Top Sells

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$319M
2
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$221M
3
AON icon
Aon
AON
+$181M
4
BMY icon
Bristol-Myers Squibb
BMY
+$180M
5
HES
Hess
HES
+$150M

Sector Composition

Rank Sector Weight
1 Healthcare 37.95%
2 Technology 14.96%
3 Financials 12.32%
4 Communication Services 7.9%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
101
Krystal Biotech
KRYS
$9.66B
$361K ﹤0.01%
2,000
– –
SLNO
102
DELISTED
Soleno Therapeutics
SLNO
$357K ﹤0.01%
5,000
-85,000
-94% -$4.14M
BPMC
103
DELISTED
Blueprint Medicines
BPMC
$354K ﹤0.01%
4,000
– –
SAGE
104
DELISTED
Sage Therapeutics
SAGE
$340K ﹤0.01%
42,800
– –
MMSI icon
105
Merit Medical Systems
MMSI
$5.32B
$317K ﹤0.01%
3,000
– –
UTHR icon
106
United Therapeutics
UTHR
$23.1B
$308K ﹤0.01%
1,000
– –
TWST icon
107
Twist Bioscience
TWST
$7.25B
$300K ﹤0.01%
7,650
– –
ONC
108
BeOne Medicines Ltd
ONC
$39.4B
$299K ﹤0.01%
1,100
– –
COR icon
109
Cencora
COR
$61.2B
$278K ﹤0.01%
1,000
– –
ACLX
110
DELISTED
Arcellx
ACLX
$262K ﹤0.01%
4,000
– –
GKOS icon
111
Glaukos
GKOS
$10.6B
$256K ﹤0.01%
2,600
– –
ANNAW
112
AleAnna Inc Warrant
ANNAW
$8.06M
$247K ﹤0.01%
990,000
– –
CHE icon
113
Chemed
CHE
$7.22B
$246K ﹤0.01%
400
– –
SBRA icon
114
Sabra Healthcare REIT
SBRA
$5.37B
$245K ﹤0.01%
14,000
– –
GATEW
115
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$238K ﹤0.01%
1,485,000
– –
INSM icon
116
Insmed
INSM
$28.6B
$229K ﹤0.01%
3,000
– –
SRRK icon
117
Scholar Rock
SRRK
$6.44B
$225K ﹤0.01%
7,000
– –
ASND icon
118
Ascendis Pharma A/S
ASND
$16.8B
$218K ﹤0.01%
+1,400
New +$200K
BRKR icon
119
Bruker
BRKR
$8.14B
$209K ﹤0.01%
5,000
– –
IMVT icon
120
Immunovant
IMVT
$8.25B
$205K ﹤0.01%
12,000
– –
HR icon
121
Healthcare Realty
HR
$6.84B
$203K ﹤0.01%
12,000
-3,252,000
-100% -$54M
TMDX icon
122
Transmedics
TMDX
$2.91B
$202K ﹤0.01%
+3,000
New +$206K
ARWR icon
123
Arrowhead Research
ARWR
$12.4B
$201K ﹤0.01%
15,800
-613,000
-97% -$11.1M
GRFS
124
Grifois
GRFS
$5.4B
$199K ﹤0.01%
28,000
– –
ELAN icon
125
Elanco Animal Health
ELAN
$11.1B
$168K ﹤0.01%
16,000
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Farallon Capital Management held 168 positions worth $20.9B, down 8.5% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $1.04B in Q1 2025, closing 22 positions and reducing 28 holdings. Its most notable exit was Airbnb, an estimated $319M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $403M.

  • Farallon Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 3,055,000 shares worth $403M.
  • Farallon Capital Management added most to Microsoft in Q1 2025, an estimated $266M increase.
  • Farallon Capital Management's biggest Q1 2025 reduction was Aon, cutting an estimated $181M.
  • Farallon Capital Management fully exited Airbnb in Q1 2025, selling an estimated $319M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $20.9B portfolio in Q1 2025.
  • Farallon Capital Management opened 18 new positions and closed 22 in Q1 2025.
  • Farallon Capital Management's portfolio value fell 8.5% quarter-over-quarter to $20.9B.

Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.